Title:
COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS
Document Type and Number:
Japanese Patent JP2023002678
Kind Code:
A
Abstract:
To provide a method of treating a solid tumor in a human patient.SOLUTION: There are provided, methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.SELECTED DRAWING: None
Inventors:
Alan Jay Korman
Nils Romberg
David Jay Fontana
Andres A. Gutierrez
Mark Jay Selby
Catherine E. Lewis
Nils Romberg
David Jay Fontana
Andres A. Gutierrez
Mark Jay Selby
Catherine E. Lewis
Application Number:
JP2022167436A
Publication Date:
January 10, 2023
Filing Date:
October 19, 2022
Export Citation:
Assignee:
BRISTOL-MYERS SQUIBB COMPANY
International Classes:
A61K39/395; A61P35/00; A61P43/00
Domestic Patent References:
JP2012500006A | 2012-01-05 | |||
JP2012250982A | 2012-12-20 |
Foreign References:
WO2013063186A2 | 2013-05-02 | |||
WO2012059858A1 | 2012-05-10 |
Other References:
完全ヒト型抗PD-1抗体「ONO-4538/BMS-936558」について, vol. [平成30年5月25日検索], JPN6018020113, 2012, ISSN: 0005166931
Attorney, Agent or Firm:
Yamato Kento
Norifumi Tomita
Fumio Inai
Manami Sasakura
Norifumi Tomita
Fumio Inai
Manami Sasakura
Previous Patent: JPWO2023002677
Next Patent: Cytochrome P450 monooxygenase inhibitors and intermediates related thereto
Next Patent: Cytochrome P450 monooxygenase inhibitors and intermediates related thereto